Genmab A/S
F:GE91
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genmab A/S
F:GE91
|
DK |
|
Ganfeng Lithium Group Co Ltd
F:39E0
|
CN |
|
E
|
Edison International
XMUN:EIX
|
US |
|
N
|
NXP Semiconductors NV
SWB:VNX
|
NL |
Wall St Price Targets
GE91 Price Targets Summary
Genmab A/S
According to Wall Street analysts, the average 1-year price target for GE91 is 30.34 EUR with a low forecast of 17.51 EUR and a high forecast of 42.01 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GE91's stock price target?
Price Target
30.34
EUR
According to Wall Street analysts, the average 1-year price target for GE91 is 30.34 EUR with a low forecast of 17.51 EUR and a high forecast of 42.01 EUR.
What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Genmab A/S?
Projected CAGR
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%
The compound annual growth rate for Operating Income over the next 8 years is 10%.
What is the Pre-Tax Income forecast for Genmab A/S?
Projected CAGR
16%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 16%.
What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%
The compound annual growth rate for Net Income over the next 8 years is 12%.
